The frequency of GSTM1 null genotype in females was slightly higher (73.09%) in control group than bladder cancer group, but there was no statistical significance (OR=0.27; 95% CI=0.07-1.09), (p=0.065). Here, GSTM1 is linked to urinary bladder cancer.